AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 MAR 7 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced the completion of the investigational arm of a clinical trial designed to evaluate uterine artery embolization (UAE) for the treatment of uterine fibroids.
The trial was approved by the U.S. Food and Drug Administration and was conducted at a number of sites throughout the United States. The investigational arm was initiated in January 2001 and completed in January 2002 using Contour PVA particles and the FasTracker Microcatheter system.
The data from the investigational arm will be compared with data from the control arm, which uses myomectomy, a standard surgical treatment.
myomectomy and hysterectomy have been the standard surgical therapies for the benign, smooth muscle tumors more commonly known as uterine fibroids. UAE is being studied as a possible alternative to myomectomy and hysterectomy. UAE is a minimally invasive procedure that blocks blood flow to the vessels feeding the ...
Source: HighBeam Research, Investigational arm of uterine artery embolization trial is...